Aleon Pharma International, Inc.
↗Parsippany, New Jersey, USA
Aleon Pharma International is a strategic regulatory affairs and clinical development consulting firm serving the pharmaceutical and biotechnology industries. The company specializes in guiding sponsor companies through complex global regulatory pathways, including FDA, EMA, and NMPA submissions, from early-stage development through to NDA/BLA approval.
With over 15 years of experience, Aleon provides services such as clinical development strategy, regulatory consulting, pharmacovigilance, and quality & compliance. They have a strong track record in various modalities, including small molecules, biologics, cell and gene therapies, ADCs, and mRNA/sRNA therapeutics, and have supported more than 125 successful Investigational New Drug (IND) applications.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Regulatory Affairs Consulting / CRO
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2010
Ownership:private
Status:operating
FUNDING
Total Raised:$0
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Small molecule, mAb, ADC, Cell therapy, Gene therapy, RNA
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:LORENZ Life Sciences Group (Technology Partner)
COMPETITION
Position:Niche Player
Competitors:Inceptua Group, SCC, CurVe Consultants, PHP Environmental Consulting
LEADERSHIP
Key Executives:
Andrew Jiang - Founder and President
LINKS
Website:aleonpharma.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Aleon Pharma International, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aleon Pharma International, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.